Valeant to bring looser terms in $5.3bn refinancing
After releasing first quarter results, Canadian drugmaker Valeant is again looking to refinance old debt with less restrictive facilities, announcing a new $5.3bn refinancing package on Thursday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts